Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen M Coley

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Nanoscience and Nanotechnology|July 5, 2012
Protamine and chloroquine enhance gene delivery and expression mediated by RNA-wrapped single walled carbon nanotubesVanesa Sanz, Helen M Coley, S Ravi P Silva, et al.
Biochimica Et Biophysica Acta|February 3, 2007
Biophysical characterization of MDR breast cancer cell lines reveals the cytoplasm is critical in determining drug sensitivityHelen M Coley, Fatima H Labeed, Hilary Thomas, et al.
Biophysical Journal|August 29, 2003
Assessment of multidrug resistance reversal using dielectrophoresis and flow cytometryFatima H Labeed, Helen M Coley, Hilary Thomas, et al.
International Journal of Nanomedicine|August 28, 2007
Rapid assessment of early biophysical changes in K562 cells during apoptosis determined using dielectrophoresisSue Chin, Michael P Hughes, Helen M Coley, et al.
Cancers|September 28, 2019
The Targeting of RNA Polymerase I Transcription Using CX-5461 in Combination with Radiation Enhances Tumour Cell Killing Effects in Human Solid CancersMohammed Ismael, Roger Webb, Mazhar Ajaz, et al.
Anti-Cancer Drugs|December 13, 2006
Mode of action of the novel phenazine anticancer agents XR11576 and XR5944Louisa J Lewis, Prakash Mistry, Peter A Charlton, et al.
Biochemical Pharmacology|August 29, 2006
Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agentsHelen M Coley, Christine F Shotton, Abi Ajose-Adeogun, et al.
Anticancer Research|October 15, 2010
Differential expression of mTOR signalling components in drug resistance in ovarian cancerHelen Foster, Helen M Coley, Anastasia Goumenou, et al.
Oncotarget|February 1, 2012
Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancerHelen M Coley, Eleftheria Hatzimichael, Sarah Blagden, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2007
The effects of cyclooxygenase-2 expression in prostate cancer cells: modulation of response to cytotoxic agentsAyaz Mehar, Patricia Macanas-Pirard, Atsushi Mizokami, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Nanoscience and Nanotechnology|July 5, 2012
Protamine and chloroquine enhance gene delivery and expression mediated by RNA-wrapped single walled carbon nanotubesVanesa Sanz, Helen M Coley, S Ravi P Silva, et al.
Biochimica Et Biophysica Acta|February 3, 2007
Biophysical characterization of MDR breast cancer cell lines reveals the cytoplasm is critical in determining drug sensitivityHelen M Coley, Fatima H Labeed, Hilary Thomas, et al.
Biophysical Journal|August 29, 2003
Assessment of multidrug resistance reversal using dielectrophoresis and flow cytometryFatima H Labeed, Helen M Coley, Hilary Thomas, et al.
International Journal of Nanomedicine|August 28, 2007
Rapid assessment of early biophysical changes in K562 cells during apoptosis determined using dielectrophoresisSue Chin, Michael P Hughes, Helen M Coley, et al.
Cancers|September 28, 2019
The Targeting of RNA Polymerase I Transcription Using CX-5461 in Combination with Radiation Enhances Tumour Cell Killing Effects in Human Solid CancersMohammed Ismael, Roger Webb, Mazhar Ajaz, et al.
Anti-Cancer Drugs|December 13, 2006
Mode of action of the novel phenazine anticancer agents XR11576 and XR5944Louisa J Lewis, Prakash Mistry, Peter A Charlton, et al.
Biochemical Pharmacology|August 29, 2006
Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agentsHelen M Coley, Christine F Shotton, Abi Ajose-Adeogun, et al.
Anticancer Research|October 15, 2010
Differential expression of mTOR signalling components in drug resistance in ovarian cancerHelen Foster, Helen M Coley, Anastasia Goumenou, et al.
Oncotarget|February 1, 2012
Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancerHelen M Coley, Eleftheria Hatzimichael, Sarah Blagden, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2007
The effects of cyclooxygenase-2 expression in prostate cancer cells: modulation of response to cytotoxic agentsAyaz Mehar, Patricia Macanas-Pirard, Atsushi Mizokami, et al.
Pageof 4